DE3781017D1 - Cytotoxische zusammensetzung aus "killer"-zellen. - Google Patents

Cytotoxische zusammensetzung aus "killer"-zellen.

Info

Publication number
DE3781017D1
DE3781017D1 DE8787303945T DE3781017T DE3781017D1 DE 3781017 D1 DE3781017 D1 DE 3781017D1 DE 8787303945 T DE8787303945 T DE 8787303945T DE 3781017 T DE3781017 T DE 3781017T DE 3781017 D1 DE3781017 D1 DE 3781017D1
Authority
DE
Germany
Prior art keywords
killer
cells
cytotoxic composition
cytotoxic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787303945T
Other languages
English (en)
Other versions
DE3781017T2 (de
Inventor
Irving L Weissman
Howard K Gershenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/948,248 external-priority patent/US4973555A/en
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Application granted granted Critical
Publication of DE3781017D1 publication Critical patent/DE3781017D1/de
Publication of DE3781017T2 publication Critical patent/DE3781017T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19873781017 1986-05-06 1987-05-01 Cytotoxische zusammensetzung aus "killer"-zellen. Expired - Fee Related DE3781017T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86008586A 1986-05-06 1986-05-06
US86122186A 1986-05-08 1986-05-08
US06/948,248 US4973555A (en) 1986-05-06 1986-12-31 Human serine protease gene

Publications (2)

Publication Number Publication Date
DE3781017D1 true DE3781017D1 (de) 1992-09-17
DE3781017T2 DE3781017T2 (de) 1993-03-18

Family

ID=27420406

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873781017 Expired - Fee Related DE3781017T2 (de) 1986-05-06 1987-05-01 Cytotoxische zusammensetzung aus "killer"-zellen.

Country Status (2)

Country Link
EP (1) EP0245051B1 (de)
DE (1) DE3781017T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673952A1 (fr) * 1991-03-14 1992-09-18 Inst Nat Sante Rech Med Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques.
JP2004501637A (ja) * 2000-06-26 2004-01-22 スージェン・インコーポレーテッド 新規プロテアーゼ
AU2002224553A1 (en) * 2000-07-21 2002-02-05 Incyte Genomics, Inc. Human proteases
AU2003225626A1 (en) * 2002-03-01 2003-09-16 Applera Corporation Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208612A (en) * 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations

Also Published As

Publication number Publication date
DE3781017T2 (de) 1993-03-18
EP0245051B1 (de) 1992-08-12
EP0245051A1 (de) 1987-11-11

Similar Documents

Publication Publication Date Title
DK184788A (da) Cytotoxisk praeparat
BR8806982A (pt) Composicao estabilizada
FR2571966B1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
BR8802017A (pt) Composicao estabilizada
FR2592763B1 (fr) Composition antiseptique
BR8700056A (pt) Composicao organopolisiloxano
FR2583763B1 (fr) Composition d'essence
FI871918A (fi) Komposition och foerfarande foer att foerhindra mikrobvaext.
FR2604180B1 (fr) Composition d'organopolysiloxane
NO162611C (no) "stoept" eksplosiv sammensetning.
BR8701454A (pt) Composicao bactericida
KR880701969A (ko) 캡슐화 조성물
BR8704087A (pt) Composicao
ES523528A0 (es) "mejoras en la preparacion de compuestos de adicion entre menadiona y tiamina".
DE3781017D1 (de) Cytotoxische zusammensetzung aus "killer"-zellen.
RO95836A (ro) Compozitie erbicida lichida
LV5649A3 (lv) Herbicida kompozicija
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
MA20974A1 (fr) Derives propargyloxybenzenes, leur preparation et compositions fongicides les contenant
DE3575727D1 (de) Herstellung von 2,6-dialkylphenoxydihalophosphiten.
FR2583416B1 (fr) Composition d'aminobenzylamines.
MC1822A1 (fr) Bacteriocines et compositions antivirales les contenant
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee